There is no single quick test for rabies in a living person or animal. In animals, rabies is confirmed by examining brain tissue after death. In humans, diagnosis requires multiple specimens collected from different parts of the body, and even then, the virus can be difficult to detect in the early stages of illness. Here’s how testing works for both animals and people, and what to expect from the process.
How Animals Are Tested
The standard test for rabies in animals is the direct fluorescent antibody test, or DFA. It has been the gold standard for decades and requires brain tissue from the animal in question, specifically from the brainstem and cerebellum. This means the animal must be dead (either euthanized or found deceased) before testing can happen. There is no approved blood test or swab that can confirm rabies in a living animal.
In the lab, a technician takes a pea-sized piece of brain tissue and presses thin impressions of it onto glass slides. Those slides are fixed in cold acetone, then treated with a fluorescent-labeled antibody that binds to the rabies virus. Under a fluorescence microscope, infected tissue lights up with bright apple-green inclusions inside the cells. These glowing spots vary in size and shape, from dust-like particles less than one micrometer across to larger oval masses. A healthy (negative) control and a known positive control are always run alongside the sample to ensure accuracy.
This is why, after a potential exposure, public health authorities often try to capture and test the animal rather than immediately starting treatment. If the DFA test on the animal comes back negative, the exposed person can avoid the post-exposure vaccine series. If the animal can’t be found or tested, treatment is typically started as a precaution.
How Humans Are Tested
Diagnosing rabies in a living person is more complex. No single specimen is reliable enough on its own, so the CDC recommends collecting four types of samples: a skin biopsy from the back of the neck, saliva, serum (blood), and cerebrospinal fluid (the liquid surrounding the brain and spinal cord).
The skin biopsy is surprisingly specific. A small section of skin, about 5 to 6 millimeters in diameter, is taken from the posterior region of the neck at the hairline. The sample must contain at least 10 hair follicles and be deep enough to include the tiny nerves at the base of those follicles. The rabies virus travels along nerves, so these nerve-rich follicles are where the virus is most likely to be found in skin.
Saliva is tested for the presence of viral genetic material. Blood and cerebrospinal fluid are checked for antibodies the immune system produces in response to the virus. The antibody results have an important distinction: if someone has never been vaccinated against rabies and antibodies show up in their blood, that alone confirms a rabies infection. But if the person has received a rabies vaccine or immune globulin (as part of post-exposure treatment, for example), blood antibodies don’t tell you much because they could simply reflect the vaccine. In that case, finding antibodies in the cerebrospinal fluid is the stronger indicator, because antibodies there suggest the virus has reached the central nervous system regardless of vaccination history.
Specimen Handling and Transport
Rabies samples are fragile and must be handled carefully to remain usable. All specimens, including skin, saliva, serum, cerebrospinal fluid, and brain tissue, should be frozen at minus 20 degrees Celsius or colder for anything beyond short-term storage. If the sample will reach the lab within three days, refrigeration is acceptable, but frozen shipping on dry ice is preferred.
Packaging must meet international biological substance shipping regulations. If transit takes fewer than three days, the package needs to arrive at 8 degrees Celsius or colder. For shipments taking 4 to 21 days, the package must arrive at minus 20 degrees Celsius or colder. Anything over 21 days in transit may not be eligible for testing at all. Specimens that arrive warm or without adequate cold packs can be rejected outright, which means a missed diagnosis and wasted time.
How Long Results Take
For animal DFA testing, most state public health laboratories can return results within 24 to 72 hours, which is one reason this test remains the standard. Speed matters when a person is waiting to find out whether they need post-exposure treatment.
Antibody-based tests take longer. The fluorescent antibody virus neutralization test, used to measure rabies antibody levels in serum, has an average turnaround time of 7 to 14 calendar days from the time the lab receives the sample. This test is more commonly used to check whether a vaccine has produced an adequate immune response, but it also plays a role in human diagnosis.
Rapid Field Tests
Lateral flow devices, similar in concept to a home pregnancy test, have been developed for rapid rabies detection in dead animals. These strip-based tests use a small brain tissue sample and can produce a result in minutes rather than hours. Some versions perform well: one widely studied kit achieved 95% sensitivity and 100% specificity when compared to the standard DFA test, meaning it caught 95 out of 100 true positives and never falsely identified a negative sample as positive.
However, performance varies dramatically between manufacturers. One kit in the same evaluation detected zero true positives, making it essentially useless. Because of this inconsistency, neither the World Health Organization nor the World Organisation for Animal Health has endorsed rapid field tests as a confirmatory tool. They may have a role in remote areas where laboratory access is limited, but a positive result from a rapid test still needs lab confirmation, and a negative result can’t be fully trusted.
Why There’s No Simple Screening Test
Rabies is unusual among infections in that the virus hides inside nerve cells and stays at low levels in the blood and other easily sampled fluids, especially early in the disease. By the time the virus is abundant enough to detect reliably, the person or animal is usually already showing symptoms. This is the core challenge of rabies diagnostics: the disease is nearly always fatal once symptoms appear, yet it’s extremely difficult to detect before that point.
For this reason, rabies prevention focuses heavily on post-exposure treatment rather than waiting for a confirmed diagnosis. If you’ve been bitten or scratched by a potentially rabid animal, the decision to start treatment is based on the circumstances of the exposure, the species involved, and whether the animal can be tested, not on testing the person who was bitten. The window between exposure and symptom onset (typically 2 to 12 weeks, though it can be longer) is when the vaccine series is effective. Once symptoms begin, testing confirms what clinicians already suspect, but treatment options become extremely limited.